The Beckley Retreat: a trip of a lifetime? A psilocybin retreat was never going to be a walk in the park, but Dipal Acharya didn’t expect the magic to be quite like this journey Evening Standard · May 29, 2024
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team Private psychedelics medicine company Beckley Psytech Ltd. has acquired 100% of clinical-stage life sciences company Eleusis Therapeutics Ltd., entitling the former to full developmental and commercial rights of the latter’s assets. Benzinga · Oct 24, 2022
These Private Psychedelics Companies Have Raised Impressive Amounts Of Money Throughout the last decade, more and more companies have popped up that are focused on discovering and developing psychedelic compounds to revolutionize the treatment of mental illness. A number of these companies, including Atai Life Sciences (NASDAQ:ATAI) and Compass Pathways (NASDAQ:CMPS) are already publicly traded. But today we will take a… Benzinga · Mar 9, 2022
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT Beckley Psytech, a private company in the psychedelics space, announced that it has begun training psychotherapists for a Phase 2 clinical trial with 5-MeO-DMT, a strong and fast-acting psychedeli Benzinga · Jan 24, 2022